Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010

Canadian Journal of Microbiology

Volumn 59, Issue 10, 2013, Pages 671-678

  Martin, Irene ^a   Sawatzky, Pam ^a   Liu, Gary ^a   Allen, Vanessa ^b   Lefebvre, Brigitte ^c   Hoang, Linda ^d   Lovgren, Marguerite ^e   Haldane, David ^f   van Caeseele, Paul ^g   Horsman, Greg ^h   Garceau, Richard ⁱ   Ratnam, Sam ^j   Wong, Tom ^k   Gilmour, Matthew ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b PUBLIC HEALTH ONTARIO   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^e PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^f QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^g CADHAM PROVINCIAL LABORATORY   (Canada)

^h Saskatchewan Disease Control Laboratory   (Canada)

ⁱ Hôpital Dr G L Dumont   (Canada)

^j Newfoundland Provincial Laboratory   (Canada)

^k PUBLIC HEALTH AGENCY OF CANADA   (Canada)

more..

Author keywords

Antibiotic resistant; Gonococci; Sequence types

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; ERYTHROMYCIN; PENICILLIN DERIVATIVE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIUM; CONCENTRATION (COMPOSITION); DILUTION; GENE EXPRESSION; INHIBITION; PUBLIC HEALTH;

ADOLESCENT; ADULT; AGAR DILUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BIOLOGICAL MONITORING; CANADA; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEMALE; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA; NEISSERIA GONORRHOEAE; NONHUMAN; PHYLOGENETIC TREE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE;

ANTI-BACTERIAL AGENTS; CANADA; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; GONORRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; PREVALENCE;

CANADA;

EID: 84885150114     PISSN: 00084166     EISSN: 14803275     Source Type: Journal    
DOI: 10.1139/cjm-2013-0357     Document Type: Article

References (32)

1. Allen, V.G., Mitterni, L., Seah, C., Rebbapragada, A., Martin, I.E., Lee, C., Siebert, H., Towns, L., Melano, R.G., and Lowe, D.E. 2013. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA, 309: 163-170. doi:10.1001/jama.2012.176575. PMID:23299608.
2. Andersson, D.I., and Hughes, D. 2011. Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol. Rev. 35: 901-911. doi:10.1111/j.1574-6976.2011.00289.x. PMID:21707669.
3. Barbee, L.A., Kerani, R.P., Dombrowski, J.C., Soge, O.O., and Golden, M.R. 2013. A retrospective comparative study of 2-drug oral and intramuscular cephalosporin treatment regimens for pharyngeal gonorrhea. Clin. Infect. Dis. 56: 1539-1545. doi:10.1093/cid/cit084. PMID:23408680.
4. Barry, P.M., and Klausner, J.D. 2009. The use of cephalosporins for gonorrhea: The impending problem of resistance. Expert Opin. Pharmacother. 10: 555-557. doi:10.1517/14656560902731993. PMID:19284360.
5. Buono, S., Wu, A., Hess, D.C., Carlson, J.S., Rauch, L., Philip, S.S., Barry, P., Bernstein, K., Klausner, J.D., and Pandori, M.W. 2012. Using the Neisseria gonorrhoeae multiantigen sequence-typing method to assess strain diversity and antibiotic resistance in San Francisco, California. Microb. Drug Resist. 18: 510-517. doi:10.1089/mdr.2011.0229. PMID:22686196.
6. Centers for Disease Control and Prevention. 2009. Sexually Transmitted Disease Surveillance 2007 Supplement, Gonococcal Isolate Surveillance Project (GISP) Annual Report 2007. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, Ga., USA. Available from http://www.cdc.gov/std/GISP2007 [accessed 30 November 2010].
7. Centers for Disease Control and Prevention. 2012. Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb. Mortal. Wkly. Rep. 61: 590-594. Available from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6131a3.htm [accessed 15 February 2013]. PMID: 22874837.
8. Centers for Disease Control and Prevention. 2013. CDC grand rounds: the growing threat of multidrug-resistant gonorrhea. MMWR Morb. Mortal. Wkly. Rep. 62: 103-106. Available from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6206a3.htm [accessed 15 February 2013]. PMID:23407126.
9. Clinical and Laboratory Standards Institute (CLSI). 2010. Performance standards for antimicrobial susceptibility testing. Twentieth Informational Supplement M100-S20. Clinical and Laboratory Standards Institute, Wayne, Penn., USA.
10. Ehret, J.M., Nims, L.J., and Judson, F.N. 1996. A clinical isolate of Neisseria gonorrhoeae with in vitro resistance to erythromycin and decreased susceptibility to azithromycin. Sex. Transm. Dis. 23: 270-272. doi:10.1097/00007435-199607000-00004. PMID:8836018.
11. Galarza, P.G., Alcala, B., Salcedo, C., Canigia, L.F., Buscemi, L., Pagano, I., Oviedo, C., and Vazquez, J.A. 2009. Emergence of high level azithromycinresistant Neisseria gonorrhoeae strain isolated in Argentina. Sex. Transm. Dis. 36: 787-788. doi:10.1097/OLQ.0b013e3181b61bb1. PMID:19734823.
12. Ison, C.A., Town, K., Obi, C., Chisholm, S., Hughes, G., Livermore, D.M., and Lowndes, C.M., on behalf of the GRASP collaborative group. 2013. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011. Lancet Infect. Dis. 13(9): 762-768. doi:10.1016/S1473-3099(13)70143-9. PMID:23764300.
13. Martin, I.M.C., Ison, C.A., Aanensen, D.M., Fenton, K.A., and Spratt, B.G. 2004. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J. Infect. Dis. 189: 1497-1505. doi:10.1086/383047. PMID:15073688.
14. Martin, I., Jayaraman, G., Wong, T., Liu, G., and Gilmour, M. 2011. Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009. Sex. Transm. Dis. 38: 892-898. doi:10.1097/OLQ.0b013e31822c664f. PMID:21934558.
15. Martin, I., Sawatzky, P., Allen, V., Hoang, L., Lefebvre, B., Mina, N., Wong, T., and Gilmour, M. 2012. Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010. Sex. Transm. Dis. 39: 316-323. doi:10.1097/OLQ.0b013e 3182401b69. PMID:22421701.
16. Ohnishi, M., Golparian, D., Shimuta, K., Saika, T., Hoshina, S., Iwasaku, K., Nakayama, S.-i., Kitawaki, J., and Unemo, M. 2011. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob. Agents Chemother. 55: 3538-3545. doi:10.1128/AAC.00325-11. PMID:21576437.
17. Palmer, H.M., Young, H., Winter, A., and Dave, J. 2008a. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. J. Antimicrob. Chemother. 62: 490-494. doi:10.1093/jac/dkn235. PMID:18552343.
18. Palmer, H.M., Young, H., Graham, C., and Dave, J. 2008b. Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing. Sex. Transm. Infect. 84: 280-284. doi:10.1136/sti.2008.029694. PMID:18256103.
19. Public Health Agency of Canada, Centre for Communicable Diseases and Infection Control, Community Acquired Infections Division. 2011. Important Notice-Public Health Information Update on the Treatment for Gonococcal Infection. Public Health Agency of Canada, Ottawa. Available from http://www.phac-aspc.gc.ca/std-mts/sti-its/alert/2011/alert-gono-eng.php [accessed 10 January 2013].
20. Saitou, N., and Nei, M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4: 406-425. PMID:3447015.
21. Starnino, S., and Stefanelli, P. 2009. Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. J. Antimicrob. Chemother. 63: 1200-1204. doi:10.1093/jac/dkp118. PMID:19357159.
22. Tamura, K., Nei, M., and Kumar, S. 2004. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc. Natl. Acad. Sci. U.S.A. 101: 11030-11035. doi:10.1073/pnas.0404206101. PMID:15258291.
23. Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., and Kumar, S. 2011. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance and maximum parsimony methods. Mol. Biol. Evol. 28: 2731-2739. doi:10.1093/molbev/msr121. PMID:21546353.
24. Tanaka, M., Koga, Y., Nakayama, H., Kanayama, A., Kobayashi, I., Saika, T., and Iyoda, T. 2011. Antibiotic-resistant phenotypes and genotypes of Neisseria gonorrhoeae isolates in Japan: identification of strain clusters with multidrugresistant phenotypes. Sex. Transm. Dis. 38: 871-875. doi:10.1097/OLQ. 0b013e31821d0f98. PMID:21844744.
25. Unemo, M., and Dillon, J.-R. 2011. Review and international recommendation of methods for typing Neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology. Clin. Microbiol. Rev. 24: 447-458. doi:10.1128/CMR.00040-10. PMID:21734242.
26. Unemo, M., Golparian, D., Syversen, G., Vestrheim, D.F., and Moi, H. 2010. Two cases of verified clinical failures using internationally recommended firstline cefixime for gonorrhoea treatment, Norway, 2010. Euro. Surveill. 15(47): pii=19721. Available from http://www.eurosurveillance.org/ViewArticle.aspx? ArticleId=19721 [accessed 25 February 2011]. PMID:21144442.
27. Unemo, M., Golparian, D., and Hestner, A. 2011a. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro. Surveill. 16: pii=19792. Available from http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19792 [accessed 8 June 2012]. PMID:21329645.
28. Unemo, M., Golparian, D., Stary, A., and Eigentler, A. 2011b. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro. Surveill. 16(43): pii=19998. Available from http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19998 [accessed 8 June 2012]. PMID:22085601.
29. Unemo, M., Golparian, D., Potočnik, M., and Jeverica, S. 2012a. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro. Surveill. 17(25): pii=20200. Available from http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20200 [accessed 25 February 2011]. PMID: 22748003.
30. Unemo, M., Golparian, D., Nicholas, R., Ohnishi, M., Gallay, A., and Sednaouie, P. 2012b. High-level cefixime-and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob. Agents Chemother. 56: 1273-1280. doi:10.1128/AAC.05760-11. PMID:22155830.
31. World Health Organization (WHO). 2012. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. World Health Organization, Geneva. Available from http://www.who.int/reproductivehealth/publications/rtis/9789241503501/en/index.html [accessed 12 June 2012].
32. Wu, A., Buono, S., Katz, K.A., and Pandori, M.W. 2011. Clinical Neisseria gonorrhoeae isolates in the United States with resistance to azithromycin possess mutations in all 23S rRNA alleles and the mtrR coding region. Microb. Drug Resist. 17: 425-427. doi:10.1089/mdr.2010.0199. PMID:21492017.